Literature DB >> 2373262

Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration.

S T Britland1, R J Young, A K Sharma, B F Clarke.   

Abstract

We evaluated neuropathological abnormalities in sural nerve biopsies from 6 nondiabetic control subjects and 16 age-matched diabetic patients with different syndromes of sensory polyneuropathy (6 with chronic painful neuropathy [CPN], 4 with newly presenting painful neuropathy [NPN], and 6 with painless neuropathy associated with recurrent neurotrophic foot ulcers [RFU]). Although all but one of the evaluated features of myelinated and unmyelinated fiber pathology could be found in every diabetic patient, certain myelinated fiber abnormalities were associated with the clinical characteristics of the neuropathy. Thus, myelinated fiber density was severely reduced, "empty" Schwann tubes (an index of myelinated fiber degeneration) were increased, and early regeneration (bands of Büngner [BB], nonmyelinated axons) was pronounced in the RFU group. Progression from BB to regenerating myelinated fiber cluster (myelination and maturation) was more successful in patients with CPN and NPN than in those with RFU, and the finding of fibers with disproportionately large Schwann cells (cytoplasm and myelin) relative to axon caliber was exclusive to patients with neuropathic pain. We concluded that 1) unequal rates of successful fiber regeneration may underlie the apparent difference in the extent of myelinated fiber loss between painful and painless diabetic polyneuropathy; 2) myelinated and unmyelinated fiber degeneration and regeneration per se are probably not the cause of neuropathic pain in diabetic polyneuropathy, because each occurred in patients with RFU; and 3) axonal atrophy may be involved in neuropathic pain generation.

Entities:  

Mesh:

Year:  1990        PMID: 2373262     DOI: 10.2337/diab.39.8.898

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  26 in total

Review 1.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

2.  Sural nerve pathology in diabetic patients with minimal but progressive neuropathy.

Authors:  R A Malik; S Tesfaye; P G Newrick; D Walker; S M Rajbhandari; I Siddique; A K Sharma; A J M Boulton; R H M King; P K Thomas; J D Ward
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

3.  Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat.

Authors:  D Walker; A Carrington; S A Cannan; D Sawicki; J Sredy; A J Boulton; R A Malik
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

Review 4.  Diagnosis and management of diabetic neuropathy.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

5.  Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy.

Authors:  S R Crosby; C Tsigos; C D Anderton; C Gordon; R J Young; A White
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

Review 6.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 7.  Diabetic neuropathy in the elderly.

Authors:  A A Sima; D A Greene
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

8.  Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy.

Authors:  Hsinlin T Cheng; Jacqueline R Dauch; Michael T Porzio; Brandon M Yanik; Wilson Hsieh; A Gordon Smith; J Robinson Singleton; Eva L Feldman
Journal:  J Pain       Date:  2013-05-17       Impact factor: 5.820

Review 9.  Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

Authors:  B Jarvis; A J Coukell
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

10.  Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuria.

Authors:  C W Bodmer; E A Masson; M W Savage; S Benbow; A W Patrick; G Williams
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.